Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 13Terminated 7Unknown 6Recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1Breast 1

Conditions

Obesity 1Neuralgia 1Inflammation 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Pregabalin × Clear all
NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting
112 enrolled
BreastOther

Breast Neoplasms, Inflammation, Obesity

NCT06766916 2025-05-18

CRYSTAL

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
172 enrolled
Head & Neck

Head and Neck Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡